Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Bimatoprost for Eyelash Hypotrichosis
NCT00907426Phase 3Completed
- Sponsor
- Allergan
- Start
- Aug 2009
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of bimatoprost in Eyelash Hypotrichosis, sponsored by Allergan. Started Aug 2009; status: completed.
02
Drugs
bimatoprost
03
Conditions
Eyelash Hypotrichosis
Beyond the preview
Go deeper on NCT00907426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907426.